DENT Neurologic Institute reposted this
This article makes me sad and functions as an important reminder that regulation is often needed as the market will not self police. At home ketamine injections is a terrible idea. A recent study concluded that 50% of home ketamine is misused. Mail order clinics such as Mindbloom are preying on patient’s conflation of dissociation with antidepressant effect. I don’t know if this is explicit or implicit, but the patients interviewed for this article consistently stated they “graduated” to injections following a lack of dissociative response. I am also saddened by the involvement of a PA within the article. Sadly, these companies have leaned heavily on PA and NP telehealth clinicians, often lacking the nessecsry experience to navigate these therapies. I don’t think the market will address this issue without government intervention. We need to update regulations to prevent bad actors whose goal is not to follow science and safety, but rather to maximize profit.